EF Hutton Assumes Buy And $14 PT On Hoth
Portfolio Pulse from Bill Haddad
EF Hutton has reiterated its Buy rating and $14 price target on Hoth Therapeutics (HOTH).
May 31, 2023 | 9:01 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
EF Hutton reiterates Buy rating and $14 price target on Hoth Therapeutics.
EF Hutton's reiterated Buy rating and $14 price target on Hoth Therapeutics (HOTH) indicates a positive outlook for the stock. This news is likely to have a positive short-term impact on HOTH's stock price as it reaffirms the confidence of a well-known financial analyst in the company's potential.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100